Anti-CD25 Daclizumab, a humanized monoclonal antibody against CD25, was not superior to placebo in a randomized, placebo-controlled, double-blind trial including 17 patients with severe ocular BD.

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria. A novel class of antibodies that binds to ...

This study uncovers a unique broad neutralization mechanism against rotavirus, where antibody 7H13 destabilizes the partial structure of the viral VP4 spike by acting on a critical residue switch ...